These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10645668)

  • 41. Increasing incidence of toxoplasma infection in eastern Uttar Pradesh.
    Mehrotra R; Baveja R
    Natl Med J India; 1997; 10(4):202. PubMed ID: 9325647
    [No Abstract]   [Full Text] [Related]  

  • 42. Risk factors for Toxoplasma gondii infection in the United States.
    Jones JL; Dargelas V; Roberts J; Press C; Remington JS; Montoya JG
    Clin Infect Dis; 2009 Sep; 49(6):878-84. PubMed ID: 19663709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mic1-3 knockout of Toxoplasma gondii is a successful vaccine against chronic and congenital toxoplasmosis in mice.
    Ismael AB; Dimier-Poisson I; Lebrun M; Dubremetz JF; Bout D; Mevelec MN
    J Infect Dis; 2006 Oct; 194(8):1176-83. PubMed ID: 16991094
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention of congenital toxoplasmosis in Norway.
    Stray-Pedersen B
    Arch Pediatr; 2003 Feb; 10 Suppl 1():23-4. PubMed ID: 12802962
    [No Abstract]   [Full Text] [Related]  

  • 45. Prevention of congenital toxoplasmosis in Austria.
    Aspöck H
    Arch Pediatr; 2003 Feb; 10 Suppl 1():16-7. PubMed ID: 12802957
    [No Abstract]   [Full Text] [Related]  

  • 46. [Argentine Consensus of Congenital Toxoplasmosis].
    Durlach R; Kaufer F; Carral L; Freuler C; Ceriotto M; Rodriguez M; Freilij H; Altcheh J; Vazquez L; Corazza R; Dalla Fontana M; Arienti H; Sturba E; Gonzalez Ayala S; Cecchini E; Salomon C; Nadal M; Gutierrez N; Guarnera E
    Medicina (B Aires); 2008; 68(1):75-87. PubMed ID: 18416325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening.
    Boyer KM; Holfels E; Roizen N; Swisher C; Mack D; Remington J; Withers S; Meier P; McLeod R;
    Am J Obstet Gynecol; 2005 Feb; 192(2):564-71. PubMed ID: 15696004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Seroprevalence and incidence of Toxoplasma gondii infection in the Legnano area of Italy.
    De Paschale M; Agrappi C; Clerici P; Mirri P; Manco MT; Cavallari S; Viganò EF
    Clin Microbiol Infect; 2008 Feb; 14(2):186-9. PubMed ID: 18034857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Continuous quality improvement in radiotherapy: the role of the "Istituto Superiore di Sanità" in its application over the national territory.
    Viti V
    Rays; 2001; 26(3):177-81. PubMed ID: 11925789
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The prevalence of Toxoplasma gondii infection among 2016 pregnant women and their children in the Institute of Mother and Child in Warsaw].
    Niemiec KT; Raczyński P; Markiewicz K; Leibschang J; Ceran A
    Wiad Parazytol; 2002; 48(3):293-9. PubMed ID: 16888975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Evaluation of the usefulness of serological examinations in the prophylaxis of congenital toxoplasmosis in the materials of CM UJ Parasitology Department].
    Dymon M; Kempińska A
    Wiad Parazytol; 2001; 47 Suppl 1():59-64. PubMed ID: 16897953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prevention of congenital toxoplasmosis in France. Risk assessment. Results and perspectives of prenatal screening and newborn follow up].
    Ambroise-Thomas P; Schweitzer M; Pinon JM; Thiebaugeorges O
    Bull Acad Natl Med; 2001; 185(4):665-83; discussion 684-8. PubMed ID: 11503357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevention of congenital toxoplasmosis.
    Foulon W; Naessens A; Ho-Yen D
    J Perinat Med; 2000; 28(5):337-45. PubMed ID: 11125923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The vaccines against toxoplasmosis--current status of the studies].
    Długońska H; Gatkowska J; Kur J; Gasior A
    Wiad Parazytol; 2007; 53(3):195-201. PubMed ID: 18075151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prevention of congenital toxoplasmosis in Europe].
    Raeber PA; Biedermann K; Just M; Zuber P
    Schweiz Med Wochenschr Suppl; 1995; 65():96S-102S. PubMed ID: 7716459
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Toxoplasmosis in Serbia: time for an action plan.
    Djurković-Djaković O; Bobić B; Klun I
    Parasite; 2010 Sep; 17(3):187-92. PubMed ID: 21073140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Toxoplasmosis screening: tu felix Austria?].
    Hassl A
    Wien Klin Wochenschr; 1998 Jan; 110(2):66-7. PubMed ID: 9531683
    [No Abstract]   [Full Text] [Related]  

  • 58. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis.
    Montoya JG
    J Infect Dis; 2002 Feb; 185 Suppl 1():S73-82. PubMed ID: 11865443
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serological screening and toxoplasmosis exposure factors among pregnant women in the Democratic Republic of Sao Tome and Principe.
    Hung CC; Fan CK; Su KE; Sung FC; Chiou HY; Gil V; da Conceicao dos Reis Ferreira M; de Carvalho JM; Cruz C; Lin YK; Tseng LF; Sao KY; Chang WC; Lan HS; Chou SH
    Trans R Soc Trop Med Hyg; 2007 Feb; 101(2):134-9. PubMed ID: 17113117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: implications for prenatal management and screening.
    Levine EM
    Am J Obstet Gynecol; 2006 Feb; 194(2):589; author reply 590. PubMed ID: 16458668
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.